title: Enhanced aggressive behaviour in a mouse model of depression.
abstract: Depression is one of the most common chronic mental disorders, which is a leading cause of morbidity and mortality in patients. Depression often leads to offensive and defensive behaviours but the underlying mechanisms are not known. We propose that the aggressive behaviours in depression can be modelled in animal experiments. In this study, we successfully established a mouse model of depression using the chronic unpredictable mild stress (CUMS) paradigm and detected aggressive and social dominance behaviours in rodents by resident/intruder test and social dominance tube test (SDTT), respectively. The CUMS-exposed mice showed increased defensive, offensive and aggressive behaviours in the resident-intruder test. In the SDTT, these mice showed enhanced social dominance. These alterations were associated with reduced MAP-2 expression in the hippocampus while no difference in β-tubulin expression was detected. In addition, the treatment of anti-depressant fluoxetine reversed the aggressive behaviours without reducing the social dominance behaviour induced by CUMS. However, fluoxetine did effectively reverted the changes in MAP-2 expression in the hippocampus. In addition, the nonspecific tricyclic antipsychotic drug, clozapine, reversed all symptoms of CUMS-exposed mice including aggressive tendencies, impulsive violence, social dominance behaviour and MAP-2 expression in the hippocampus. The results suggests that social maladjustment such as competition and social dominance are likely related to the dopaminergic system rather than the serotonergic system and the hippocampal dendritic structure protein MAP-2. Thus, dominance can be separated from aggression. This study shows that aggression/hostility and social hierarchy/dominance are increased in the CUMS-exposed mice and thus provide an excellent model for further study in the diagnosis and the treatment of depression-associated aggression.
authors.affiliation: Department of Pathology, Second Hospital of Tianjin Medical University, Tianjin, People's Republic of China.
authors.forename: C R
authors.initials: CR
authors.lastname: Yang
authors.forename: Y Y
authors.initials: YY
authors.lastname: Bai
authors.forename: C S
authors.initials: CS
authors.lastname: Ruan
authors.forename: H F
authors.initials: HF
authors.lastname: Zhou
authors.forename: D
authors.initials: D
authors.lastname: Liu
authors.forename: X F
authors.initials: XF
authors.lastname: Wang
authors.forename: L J
authors.initials: LJ
authors.lastname: Shen
authors.forename: H Y
authors.initials: HY
authors.lastname: Zheng
authors.forename: X F
authors.initials: XF
authors.lastname: Zhou
mesh_terms: D000374:Aggression / Q000187:drug effects; D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology; D003024:Clozapine / Q000494:pharmacology; D003866:Depressive Disorder / Q000209:etiology / Q000378:metabolism / Q000523:psychology*; D004195:Disease Models, Animal; D005473:Fluoxetine / Q000494:pharmacology; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012930:Social Dominance; D013315:Stress, Psychological / Q000150:complications
chemical_list: D018687:Antidepressive Agents, Second-Generation; D008869:Microtubule-Associated Proteins; C079240:Mtap2 protein, mouse; D012333:RNA, Messenger; D005473:Fluoxetine; D003024:Clozapine